Mark P. Hudson

658 total citations
11 papers, 518 citations indexed

About

Mark P. Hudson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Rheumatology. According to data from OpenAlex, Mark P. Hudson has authored 11 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Rheumatology. Recurrent topics in Mark P. Hudson's work include Alzheimer's disease research and treatments (3 papers), Cellular transport and secretion (3 papers) and Nerve injury and regeneration (3 papers). Mark P. Hudson is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Cellular transport and secretion (3 papers) and Nerve injury and regeneration (3 papers). Mark P. Hudson collaborates with scholars based in United States, United Kingdom and Japan. Mark P. Hudson's co-authors include Mark Bothwell, Jesse C. Wiley, Leslayann Schecterson, Kevin C. Kanning, Paul S. Amieux, Nan Hatch, Michael L. Cunningham, Marianne L. Seto, David Jones and Mark Philo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and American Journal of Clinical Nutrition.

In The Last Decade

Mark P. Hudson

10 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark P. Hudson United States	10	292	214	127	84	60	11	518
Katsumi Komatsuzaki United States	9	382 1.3×	340 1.6×	175 1.4×	22 0.3×	35 0.6×	11	611
Francisco Llavero Spain	13	180 0.6×	58 0.3×	113 0.9×	46 0.5×	12 0.2×	18	390
Kenneth W. Henry United States	12	226 0.8×	159 0.7×	204 1.6×	10 0.1×	43 0.7×	17	468
Laure Duplan France	7	230 0.8×	148 0.7×	76 0.6×	11 0.1×	43 0.7×	7	427
Ester Quintana Spain	17	364 1.2×	34 0.2×	76 0.6×	42 0.5×	23 0.4×	31	637
Şafak Çağlayan Germany	8	191 0.7×	68 0.3×	182 1.4×	17 0.2×	16 0.3×	11	351
Mary Nivison United States	9	302 1.0×	80 0.4×	80 0.6×	11 0.1×	112 1.9×	14	601
Keigo Goto Japan	10	210 0.7×	226 1.1×	99 0.8×	16 0.2×	14 0.2×	15	541
Runa Araya Japan	9	222 0.8×	68 0.3×	33 0.3×	66 0.8×	13 0.2×	9	381
Antoine Bach France	6	314 1.1×	67 0.3×	71 0.6×	19 0.2×	32 0.5×	9	454

Countries citing papers authored by Mark P. Hudson

Since Specialization

Citations

This map shows the geographic impact of Mark P. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Hudson more than expected).

Fields of papers citing papers by Mark P. Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Hudson. The network helps show where Mark P. Hudson may publish in the future.

Co-authorship network of co-authors of Mark P. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Hudson. A scholar is included among the top collaborators of Mark P. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Hudson. Mark P. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hudson, Mark P., et al.. (2025). Acute Chemodenervation of the Bladder With Botulinum Toxin After Spinal Cord Injury Resulted in Preserved Bladder Function in Rodents. Neurourology and Urodynamics. 44(8). 1704–1712.

Meabon, James S., Rian de Laat, Katsuaki Ieguchi, et al.. (2015). LINGO-1 Protein Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments. Journal of Biological Chemistry. 290(15). 9511–9520. 16 indexed citations

Laat, Rian de, James S. Meabon, Jesse C. Wiley, et al.. (2015). LINGO-1 promotes lysosomal degradation of amyloid-β protein precursor. PubMed. 5(1). 25796–25796. 17 indexed citations

Meabon, James S., Rian de Laat, Katsuaki Ieguchi, et al.. (2015). Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling. Molecular and Cellular Neuroscience. 70. 1–10. 16 indexed citations

Patanwala, Imran, David A. Barrett, John Rose, et al.. (2014). Folic acid handling by the human gut: implications for food fortification and supplementation. American Journal of Clinical Nutrition. 100(2). 593–599. 95 indexed citations

Li, Yan, Jin Liu, Mark P. Hudson, Sung‐Su Kim, & Nan Hatch. (2010). FGF2 promotes Msx2 stimulated PC‐1 expression via Frs2/MAPK signaling. Journal of Cellular Biochemistry. 111(5). 1346–1358. 13 indexed citations

Schecterson, Leslayann, Mark P. Hudson, Huaibin M. Ko, et al.. (2010). Trk activation in the secretory pathway promotes Golgi fragmentation. Molecular and Cellular Neuroscience. 43(4). 403–413. 20 indexed citations

Wiley, Jesse C., Elise Smith, Mark P. Hudson, Warren Ladiges, & Mark Bothwell. (2007). Fe65 Stimulates Proteolytic Liberation of the β-Amyloid Precursor Protein Intracellular Domain. Journal of Biological Chemistry. 282(46). 33313–33325. 27 indexed citations

Hatch, Nan, Mark P. Hudson, Marianne L. Seto, Michael L. Cunningham, & Mark Bothwell. (2006). Intracellular Retention, Degradation, and Signaling of Glycosylation-deficient FGFR2 and Craniosynostosis Syndrome-associated FGFR2C278F. Journal of Biological Chemistry. 281(37). 27292–27305. 59 indexed citations

10.

Wiley, Jesse C., Mark P. Hudson, Kevin C. Kanning, Leslayann Schecterson, & Mark Bothwell. (2005). Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment. Journal of Neurochemistry. 94(5). 1189–1201. 54 indexed citations

11.

Kanning, Kevin C., Mark P. Hudson, Paul S. Amieux, et al.. (2003). Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability. Journal of Neuroscience. 23(13). 5425–5436. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact